Equity Profile

BHC

Bausch Health Companies Inc.

Health CarePharmaceuticals$2.4B

Jul29Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Bausch Health Companies Inc. (BHC) operates in the health care sector, focusing on pharmaceuticals....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will help gauge how well BHC is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BHC Q2-2026 Earnings Preview

Context

Company Snapshot

Bausch Health Companies Inc. (BHC) operates in the health care sector, focusing on pharmaceuticals. The company is known for its diverse portfolio of medical products, including eye health and dermatology treatments, making it a significant player in the health care landscape.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-77.46%

Avg Stock Reaction

-1.15%

Last Quarter Recap

In Q1-2026, Bausch Health reported an EPS of $0.78, falling short of the expected $0.81. The stock reacted negatively, declining by 1.41% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for BHC are cautious, given its recent history of missing earnings estimates. Investors are looking for signs of improvement in both EPS and revenue growth.

Bull Case

If BHC can exceed EPS expectations and show strong revenue growth, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company continues its trend of missing estimates, it could lead to further declines in stock price and investor sentiment.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's recent struggles with profitability, the EPS figure will be critical in determining market sentiment and future expectations.

How is revenue trending in key segments?

Understanding revenue performance in critical areas will help assess the company's growth potential and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating BHC's potential for recovery, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

The options market suggests a significant move, indicating that traders are anticipating a surprise.

BHC's recent investments in new product lines may not be fully reflected in current earnings expectations.

Key Risk

If the company reports an EPS above $0.80, it could challenge the current bearish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate centers around whether BHC can turn around its recent trend of disappointing earnings and revenue growth.

Bull Confirmed If

A significant EPS beat, such as exceeding $0.85, would confirm the bull case and suggest a recovery in profitability.

Bear Confirmed If

An EPS below $0.70 would reinforce the bear case, indicating ongoing challenges in the company's financial performance.

Pre-Earnings Positioning

Options Market

Implied Move

±13.32%

Historical Avg

±2.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±13.3% while BHC has averaged ±2.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

32.3%

Calls (64K)P/C Ratio: 0.10Puts (21K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BHC beats expectations, history suggests a potential stock increase of around 3% on the first day, confirming a positive shift in investor sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement, as investors await further guidance.

Miss

A miss could lead to a decline of about 1.15% on the first day, reflecting continued investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management and profitability strategies.
3Insights into market share changes in key therapeutic areas.
4Guidance on future earnings expectations and growth initiatives.
5Responses to analyst questions about competitive pressures.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Bausch Health Companies Inc. (BHC) operates in the health care sector, focusing on pharmaceuticals....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of a company's profitability and will help gauge how well BHC is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BHC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-77.46%

Avg Stock Reaction

-1.15%

Last Quarter Recap

In Q1-2026, Bausch Health reported an EPS of $0.78, falling short of the expected $0.81. The stock reacted negatively, declining by 1.41% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for BHC are cautious, given its recent history of missing earnings estimates. Investors are looking for signs of improvement in both EPS and revenue growth.

Bull Case

If BHC can exceed EPS expectations and show strong revenue growth, it could signal a turnaround and boost investor confidence.

Bear Case

Conversely, if the company continues its trend of missing estimates, it could lead to further declines in stock price and investor sentiment.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's recent struggles with profitability, the EPS figure will be critical in determining market sentiment and future expectations.

How is revenue trending in key segments?

Understanding revenue performance in critical areas will help assess the company's growth potential and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating BHC's potential for recovery, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

The options market suggests a significant move, indicating that traders are anticipating a surprise.

BHC's recent investments in new product lines may not be fully reflected in current earnings expectations.

Key Risk

If the company reports an EPS above $0.80, it could challenge the current bearish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate centers around whether BHC can turn around its recent trend of disappointing earnings and revenue growth.

Bull Confirmed If

A significant EPS beat, such as exceeding $0.85, would confirm the bull case and suggest a recovery in profitability.

Bear Confirmed If

An EPS below $0.70 would reinforce the bear case, indicating ongoing challenges in the company's financial performance.

Pre-Earnings Positioning

Options Market

Implied Move

±13.32%

Historical Avg

±2.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.

Options are pricing ±13.3% while BHC has averaged ±2.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

32.3%

Calls (64K)P/C Ratio: 0.10Puts (21K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If BHC beats expectations, history suggests a potential stock increase of around 3% on the first day, confirming a positive shift in investor sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement, as investors await further guidance.

Miss

A miss could lead to a decline of about 1.15% on the first day, reflecting continued investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management and profitability strategies.
3Insights into market share changes in key therapeutic areas.
4Guidance on future earnings expectations and growth initiatives.
5Responses to analyst questions about competitive pressures.